| Statement regarding final dividend declared on 7 June 2022 |
27 Jul 2022 |
| IDH reports 1Q2022 results |
8 Jun 2022 |
| IDH reports FY2021 results |
21 Apr 2022 |
| IFC and IFC MENA Fund acquire 5% stake in IDH |
31 Mar 2022 |
| IDH launches fifth Al-Borg Scan branch in West Cairo’s Capital Business Park |
29 Mar 2022 |
| IDH Welcomes Visit from Siemens Healthineers |
27 Mar 2022 |
| IDH announces the appointment of Ms Yvonne Stillhart as a Non-Executive Director of the Company |
1 Mar 2022 |
| Pakistan's Ambassador to Egypt visits IDH headquarters to explore relationships between IDH and Pakistani companies |
23 Jan 2022 |
| IDH to acquire Evercare Group’s 50% stake in Islamabad Diagnostic Centre (IDC) |
20 Dec 2021 |
| IDH reports 9M2021 results |
16 Nov 2021 |
| IDH launches third Al-Borg Scan branch in East Cairo’s centrally-located Heliopolis neighbourhood |
4 Oct 2021 |
| IDH reports 1H2021 results |
2 Sep 2021 |
| Biolab selected as preferred bidder to operate testing stations in Amman’s Queen Alia International Airport |
18 Aug 2021 |
| IDH reports 1Q2021 results |
2 Jun 2021 |
| IDH partners with IFC on USD 45M debt financing |
25 May 2021 |
| IDH’s dual-listed ordinary shares begin trading today on the Egyptian Exchange, complementary to their trading on the LSE |
20 May 2021 |
| IDH reports FY20 results |
18 May 2021 |
| IDH receives approval from the Egyptian Exchange for the dual listing of its ordinary shares |
5 May 2021 |
| IDH receives FRA registration approval as a preliminary step for its dual listing and trading on the Egyptian Exchange |
22 Mar 2021 |
| CEO Dr. Hend El Sherbini — cover story in Forbes Middle East (20 mb pdf download) |
13 Apr 2020 |
| Covid-19 protocols statement |
24 Mar 2020 |
